Skip to main content
Caplight Logo









Siwei Biotechnology

Siwei Biotechnology

Private
ShanghaiHealthcare & Life Scienceshttps://stemirna.com

Last Round

Pre-D

May 25, 2023

Est. Valuation

$153M

Total Funding Raised

$239.88M

Company Overview

Siwei Biotechnology is a biotechnology company that develops mRNA-based therapeutics and vaccines for cancer, infectious diseases, and genetic disorders using its proprietary LPP delivery technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

CDMOcontract development and manufacturing organizationCROcontract research organizationmRNA platformmRNA manufacturingmRNA therapeuticsmRNA vaccinesLPP delivery platformpharma outsourcingnanoparticle drug deliverypersonalized cancer vaccinescancer immunotherapyinfectious disease vaccines

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Siwei Biotechnology Comparables

Compare Siwei Biotechnology with similar companies based on industry and business-model similarity.

Siwei Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Enorna Biotechnology
82%
Zhejiang Innoforce Pharmaceuticals
80%
Vernal Biosciences
79%

Siwei Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre-DMay 25, 2023
Series CJun 1, 2021
Series BDec 1, 2020
Series A ExtensionFeb 1, 2020
Series AAug 11, 2019
Angel
Jul 1, 2017

Siwei Biotechnology Investors

Notable investors and investment history

Siwei Biotechnology investors
InvestorRounds
Longmen CapitalSeries A
Greenwoods Asset ManagementSeries C
招银国际金融有限公司Series C
Shanghai Zhangjiang Torch Venture CapitalSeries A
Triwise CapitalSeries A Extension
CITIC GroupSeries C
Qingsong FundSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 25, 2023

    $29M raised in latest financing.

  • Jun 1, 2021

    $200M round led by Sequoia Capital and China Merchants Health.

Siwei Biotechnology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Siwei Biotechnology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Siwei Biotechnology's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range3
Year Founded2016
Last FundingMay 25, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?